Search Icon

PLOS ONE   |  April 22, 2010

Read the Publication

Short cycle treatment interruption could reduce toxicity and drug costs and contribute to further expansion of antiretroviral therapy (ART) programs.

Read more here

Issues

HIV/AIDS

Latest publications See All